Shilpa Medicare : Q4 2024 Financial Quarterly Report : YoY Sales Up 31.52 %, QoQ Up 36.69 %

The comprehensive analytics outlining the performance and outlook of Shilpa Medicare Ltd.”s stock. This analysis encompasses various metrics including stock performance, investor sentiment, market trends, future outlook, risk factors, investment opportunities, long-term strategy, dividend policy, analyst insights, and the overall risk-reward profile. These insights aim to provide investors with a holistic understanding of the company”s stock, enabling informed decision-making and strategic investment planning.

Today, we’re looking at Shilpa Medicare Ltd.’s financial performance for the Q4(Mar 2024).Starting with the top line, the company reported a robust year-over-year sales growth of 31.52 %. However, it did see a marginal increase of 36.69 % from the previous quarter. Expenses ticked up slightly by 19.63 % quarter-on-quarter, aligning with the annual rise of 0.29 %. Operating profit, while up 150.54 % compared to last year, faced a quarter-on-quarter increase of 310.91 %, signaling a short-term expansion in margins.
The Operating Profit Margin (OPM) % echoes this narrative, showing resilience on an annual basis with an increase of 28.67 %, but an expansion of 13.12 % sequentially. Other income rose by 4.12 % compared to the last quarter, despite an annual growth of 14.36 %. Interest expenses surged remarkably by 3.83 % from the previous quarter, yet the year-over-year decrease remains at a moderate -59 %. Depreciation costs fell by -0.81 % quarter-on-quarter, whereas on an annual scale, they saw an increase of 2.59 %. Profit before tax grew annually by 226.43 % but saw an increase from the preceding quarter by 277.42 %.
Tax expenses as a percentage of profits increased slightly by 21.95 % compared to last year, with a more notable quarter-on-quarter decrease of -16.22 %. Net profit rose by 133.67 % year-on-year but experienced a 260.74 % expansion from the last quarter. And finally, Earnings Per Share (EPS) displayed an annual uptick of 133.63 % but a quarterly rise of 261.29 %. In summary, Shilpa Medicare Ltd.’s annual performance indicates steady growth, although the quarter-on-quarter figures suggest some areas may require strategic attention.

In reviewing Shilpa Medicare Ltd.’s 2024(Q4) financial snapshot, key trends emerge, shedding light on the company’s performance.Sales saw a robust 31.52 % year-on-year growth, however, there was a minor increase of 36.69 % from the previous quarter. Expenses rose by 0.29 % compared to the previous year, with a 19.63 % increase quarter-on-quarter. Operating Profit surged by 150.54 % annually, and saw a 310.91 % increase from the last quarter.
Net Profit showed yearly increase of 133.67 %, and experienced a 260.74 % increase from the previous quarter. Earnings Per Share (EPS) rose by 133.63 % annually, however rose by 261.29 % compared to the last quarter. In essence, while Shilpa Medicare Ltd. exhibits strong annual growth indicators, short-term improvements suggest the potential for recovery and the importance of strategic adjustments to counter market challenges effectively. That’s all for now in the financial sector.